Cachet Pharmaceutical Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Jiashitang Pharmaceutical Co., Ltd. was established in 1997, listed on the Shenzhen Stock Exchange in 2010 (Jiashitang, 002462), and entered the Everbright system in 2018. It is the main platform for the Everbright Health business sector. Ranked 11th in the national pharmaceutical commercial enterprise rankings in 2021. Under the strong leadership of the Party Committee of Everbright Group and the strategic guidance of building a world-class financial holding group with global competitiveness, Jiashitang adheres to the vision of "health and happiness accompany a better life", adheres to the concept of "innovation, technology, and transcendence", actively grasps market changes, implements reform and innovation, and expands innovative business with information technology as support, comprehensively improving drug sales, medical device sales, and drug retail The competitive strength of pharmaceutical logistics and innovative business is committed to becoming a leading pharmaceutical commercial and comprehensive medical rehabilitation service provider in China. The company's main business includes sales of secondary and tertiary hospitals, sales of community medical centers, logistics and distribution, and chain retail. Business scope: pharmaceuticals, biological products, medical devices, traditional Chinese medicine slices, etc. |
| Headquarter | Beijing |
| Establish Date | 4/22/1997 |
| Listed Code | 002462.SZ |
| Listed Date | 8/18/2010 |
| Chairman | Xu Wenli. |
| CEO | Huang Yibin, Xu Wenli. |
| Website | www.cachet.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
